{
    "clinical_study": {
        "@rank": "89019", 
        "arm_group": {
            "arm_group_label": "Light Weight Breast Implants", 
            "arm_group_type": "Experimental", 
            "description": "Assessment of Safety and Efficacy of Light Weight Breast Implant"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate safety and effectiveness of Light Weight Breast\n      Implant (LWBI) in breast augmentation."
        }, 
        "brief_title": "Assessment of Safety & Efficacy of Light Weight Breast Implant", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Capsular Contracture of Breast Implant, Sequela", 
        "condition_browse": {
            "mesh_term": "Contracture"
        }, 
        "detailed_description": {
            "textblock": "This is a Single-center.  The purpose of the study is to evaluate safety and effectiveness\n      of LWBI in breast augmentation."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Genetic women at ages 22 to 65 seeking breast enlargement\n\n          -  Signed informed consent\n\n          -  Agreement to complete all required follow up visits\n\n          -  A medically acceptable candidate\n\n          -  Sufficient breast tissue for proper implant coverage (\u226520 mm by pinch test)\n\n        Exclusion Criteria:\n\n          -  Patients with active infection anywhere in their body\n\n          -  Women who are currently pregnant or nursing\n\n          -  Insufficient tissue covering in the prospective area of implantation (e.g. after\n             preceding breast reduction), radiation damage or reduced vascularization\n\n          -  Abscesses, cysts or tumors in the area of implants, especially cancer and recurrent\n             metastases (e.g. persistent or intermittent mammary cancer), advanced fibrocystic\n             diseases\n\n          -  Patients with a history of psychiatric treatment\n\n          -  Expected allergies or extraordinary immune response to implants\n\n          -  Wound healing impairments or heavy burn scars\n\n          -  Existing costal injuries"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "22 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01874652", 
            "org_study_id": "0007-13-BNZ"
        }, 
        "intervention": {
            "arm_group_label": "Light Weight Breast Implants", 
            "description": "Light Weight Breast Implants", 
            "intervention_name": "Light Weight Breast Implants", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 1, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Haifa", 
                    "country": "Israel"
                }, 
                "name": "Bnai Zion"
            }
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "1", 
        "official_title": "Assessment of Safety & Efficacy of Light Weight Breast Implant", 
        "overall_official": {
            "affiliation": "Bnai-Zion", 
            "last_name": "Noam Calderon, md", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "No reoperation during 6 months follow up period", 
            "safety_issue": "Yes", 
            "time_frame": "during 6 months follow up period"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01874652"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "\u2022  duration for all adverse events (AEs) on per patient and per implant basis will be recorded and analyzed.", 
            "safety_issue": "Yes", 
            "time_frame": "6 month"
        }, 
        "source": "Bnai Zion Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bnai Zion Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}